chronic obstructive pulmonary disease

Lupin gets UK MHRA nod for generic drug to manage COPD, asthma

Drug maker Lupin on Friday said its UK-based unit has received approval to market a generic product indicated for the management of chronic obstructive pulmonary disease (COPD)